|
SLNCF Silence Therapeutics plc 1479615 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-12,268,000.00 |
| Balance Sheet |
|
Current Assets
|
$94,281,000.00 |
|
Assets
|
$106,412,000.00 |
|
Current Liabilities
|
$12,714,000.00 |
|
Liabilities
|
$67,941,000.00 |
|
Equity
|
$38,471,000.00 |
|
Shares Out
|
141739180.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-14,085,000.00 |
|
Investing Cash Flow
|
$74,940,000.00 |
| Market Analysis |
Market Cap
|
$779,565,490.00 |
|
Price
|
$5.50 |
|
BVPS
|
0.27 |
|
PB
|
20.37 |
|
EPS
|
-0.09 |
|
PS
|
125.92 |
|
FCF
|
$-14,085,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:13 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:03 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLNCF documents filed with the SEC.
SLNCF Filings
Clear
